Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Assets Average (2018 - 2026)

Trafalgar International (GCAN) posted Assets Average of $1127.0 for Q1 2026, down 89.83% on a QoQ basis from $11085.0 in Q4 2025, and down 97.83% year-over-year from $51999.0 in Q1 2025.

Analysis

Trafalgar International (GCAN) Assets Average (2018 - 2026) Analysis & Trends

Trafalgar International has reported Assets Average for 9 years, with the latest figure at $1127.0 in Q1 2026.

  • On a quarterly basis, Assets Average fell 97.83% year-over-year to $1127.0 in Q1 2026; TTM through Mar 2026 was $1127.0, a 97.83% decrease from a year earlier, with the FY2025 full-year figure at $29300.0, down 74.53% from the prior year.
  • Assets Average was $1127.0 for Q1 2026 at Trafalgar International, down from $11085.0 in the prior quarter.
  • The five-year high for Assets Average was $387346.5 in Q1 2022, with the low at $1127.0 in Q1 2026.
  • Average Assets Average over 5 years is $165039.8, with a median of $152883.0 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Assets Average soared 40.15% in 2022, then plunged 97.83% in 2026.
  • Over 5 years, Assets Average stood at $290604.0 in 2022, then plunged by 34.88% to $189237.5 in 2023, then slumped by 67.84% to $60867.0 in 2024, then plunged by 81.79% to $11085.0 in 2025, then plunged by 89.83% to $1127.0 in 2026.
  • The last three Assets Average figures came in at $1127.0 (Q1 2026), $11085.0 (Q4 2025), and $24033.5 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 200.98 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 135.79 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 129.24 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 120.28 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 204.57 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 149.95 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 3.29 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 7.61 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 6.97 Bn
10 Trafalgar International 217,335.05 217,335.05 - 1,127.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,127.00
Dec 31, 2025 11,085.00
Sep 30, 2025 24,033.50
Jun 30, 2025 36,462.50
Mar 31, 2025 51,999.00
Dec 31, 2024 60,867.00
Sep 30, 2024 73,591.00
Jun 30, 2024 108,361.50
Mar 31, 2024 152,883.00
Dec 31, 2023 189,237.50
Sep 30, 2023 227,431.50
Jun 30, 2023 254,692.00
Mar 31, 2023 270,583.50
Dec 31, 2022 290,604.00
Sep 30, 2022 312,437.50
Jun 30, 2022 352,935.00
Mar 31, 2022 387,346.50
Dec 31, 2021 451,356.00
Sep 30, 2021 546,686.00
Jun 30, 2021 478,118.00